Tools & Calculators
Sector: Pharmaceuticals & Biotechnology
|Small Cap
Innova Captab Ltd.
₹690
₹661.70
₹694.00
₹624.00
₹1020.70
Markets Today
Historical Performance
Indicator | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|
| Total Revenue | 363.73 | 289.83 | 286.98 | 242.52 | 248.52 |
| Operating Expense | 316.73 | 260.51 | 252.16 | 214.34 | 216.03 |
| Operating Profit | 47 | 29.32 | 34.82 | 28.18 | 32.49 |
| Depreciation | 9.41 | 9.48 | 9.08 | 7.81 | 3.08 |
| Interest | 3.47 | 5.21 | 2.77 | 1.87 | 0.13 |
| Tax | 9.42 | 4.94 | 7 | 5.73 | 8.37 |
| Net Profit | 27.90 | 14.33 | 20.30 | 17.12 | 24.40 |
₹690.00
↗ Bullish Moving Average
2
↘ Bearish Moving Average
14
| Held By | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|
| Promoter | 50.9 | 50.9 | 50.9 | 50.9 | 50.9 | 50.9 |
| FII | 1 | 0.7 | 0.4 | 0.2 | 0.1 | 0.1 |
| DII | 20.6 | 20 | 19.7 | 19.7 | 20.1 | 20.2 |
| Public | 27.5 | 28.4 | 29 | 29.2 | 28.9 | 28.8 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 6.22 K | 13.15 K | 47.28% |
| Week | 32.26 K | 41.35 K | 78.02% |
| 1 Month | 28.2 K | 1.27 L | 22.29% |
| 6 Month | 23.27 K | 66.53 K | 34.98% |
Positive Breakout First Resistance ( LTP > R1)
Benjamin Graham Value Screen
Buy Zone: Stocks in the buy zone based on days traded at current PE and P/BV
Relative Outperformance versus Industry over 1 Month
Good quarterly growth in the recent results
Relative Outperformance versus Industry over 1 Month
Growth in Net Profit with increasing Profit Margin (QoQ)
Companies with Low Debt
Increasing Revenue every quarter for the past 3 quarters
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Top Gainers
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 30 Jan, 2026 | 2 | INTERIM | 30 Jan, 2026 | Equity Share |
Financials | |||||
|---|---|---|---|---|---|
| Price (₹) | ₹8.43 | ₹104 | ₹115.35 | ₹604 | ₹791.10 |
| % Change | 4.98% | -1.38% | -3.98% | -1.99% | -2.37% |
| Revenue TTM (₹ Cr) | ₹104.12 | ₹282.74 | - | ₹488.20 | ₹588.52 |
| Net Profit TTM (₹ Cr) | ₹-24.37 | ₹15.30 | - | ₹56.90 | ₹101.60 |
| PE TTM | -2.90 | 26.50 | - | 30.70 | 36.00 |
| 1 Year Return | 743 | -17.19 | 27.77 | 0.89 | 41.16 |
| ROCE | -5.63 | - | - | 23.87 | 9.34 |
Valiant Laboratories Ltd.
₹ 59.10
+1.37%
Sigachi Industries Ltd.
₹ 21.22
-3.68%
Windlas Biotech Ltd.
₹ 774.00
-0.82%
Vineet Laboratories Ltd.
₹ 31.51
-1.62%
Solara Active Pharma Sciences Ltd.
₹ 472.60
+0.23%
Zim Laboratories Ltd.
₹ 72.00
+1.72%
Medico Remedies Ltd.
₹ 48.00
+4.53%
Dishman Carbogen Amcis Ltd.
₹ 182.40
+0.07%
Lasa Supergenerics Ltd.
₹ 8.05
+2.42%
Advanced Enzyme Technologies Ltd.
₹ 313.00
+0.02%
Bajaj Healthcare Ltd.
₹ 348.00
-1.29%
Ortin Global Ltd.
₹ 18.91
-4.97%
Brooks Laboratories Ltd.
₹ 72.62
-2.48%
RPG Life Sciences Ltd.
₹ 1915.00
+0.59%
Bafna Pharmaceuticals Ltd.
₹ 111.50
-1.11%
Alpa Laboratories Ltd.
₹ 68.45
+2.30%
Sun Pharma Advanced Research Company Ltd.
₹ 127.75
-1.13%
SMS Pharmaceuticals Ltd.
₹ 375.20
+0.74%
Nectar Lifesciences Ltd.
₹ 12.70
+0.63%
Mangalam Drugs and Organics Ltd.
₹ 31.15
-1.61%
Indoco Remedies Ltd.
₹ 200.10
+0.93%
Ind-Swift Laboratories Ltd.
₹ 146.60
+3.32%
Lincoln Pharmaceuticals Ltd.
₹ 619.00
-0.58%
Panacea Biotec Ltd.
₹ 338.80
-0.79%
By signing up I certify terms, conditions & privacy policy